Collectively, these in vivo data confirm the aforementioned cellular data and support the notion that the K70Q mutant of ALDH1L2 inhibits tumor growth and improves the sensitivity of CRC to 5-Fu. This evidence concerns the gene ALDH1L2 and colorectal carcinoma.